Probiotics in critical illness - Is there a role in intensive care?

Probiotics are living microbes, when adequately ingested confer benefits to the host which include shortened duration of infection or decreased susceptibility to pathogens. Probiotics improve gut banier function, restore non-pathogenic digestive flora, prevent colonization by pathogenic bacteria and...

Full description

Saved in:
Bibliographic Details
Main Authors: Hema Kumar (Author), Rakshay Shetty (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_84f0a6bf370547d2bc3f8b9f6c153acd
042 |a dc 
100 1 0 |a Hema Kumar  |e author 
700 1 0 |a Rakshay Shetty  |e author 
245 0 0 |a Probiotics in critical illness - Is there a role in intensive care? 
260 |b Wolters Kluwer Medknow Publications,   |c 2015-01-01T00:00:00Z. 
500 |a 2349-6592 
500 |a 2455-7099 
500 |a 10.21304/2015.0202.00063 
520 |a Probiotics are living microbes, when adequately ingested confer benefits to the host which include shortened duration of infection or decreased susceptibility to pathogens. Probiotics improve gut banier function, restore non-pathogenic digestive flora, prevent colonization by pathogenic bacteria and have role in immunomodulation. In the era of increasing antibacterial resistance and fewer new antibiotics in the research pipeline, non-antibiotic approaches like use of probiotics offer a ray of hope to clinician in the prevention of nosocomial infections in critical ill patients. Till to date, trials conducted on the role of probiotics in critically ill patients have shown significant heterogenicity in clinical outcomes, type of strain studied, dose and duration of therapy. Hence, the current data does not offer sufficient evidence to draw a conclusion regarding clinical indications of probiotics in critically ill. Well designed clinical trials are needed to validate the effects of particular probiotics given at specific dosages and for specific treatment durations. Although probiotics are generally safe in critically ill, more information is needed on safety profile of probiotics particularly in immunocompromised patients. 
546 |a EN 
690 |a probiotics 
690 |a critically ill. nosocomial infections 
690 |a multiorgan dysfunction 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Journal of Pediatric Critical Care, Vol 2, Iss 2, Pp 18-22 (2015) 
787 0 |n http://www.jpcc.org.in/article.asp?issn=2349-6592;year=2015;volume=2;issue=2;spage=18;epage=22;aulast=Kumar 
787 0 |n https://doaj.org/toc/2349-6592 
787 0 |n https://doaj.org/toc/2455-7099 
856 4 1 |u https://doaj.org/article/84f0a6bf370547d2bc3f8b9f6c153acd  |z Connect to this object online.